Hypoxia favors chemoresistance in T-ALL through an HIF1α-mediated mTORC1 inhibition loop

Resistance to chemotherapy, a major therapeutic challenge in the treatment of T-cell acute lymphoblastic leukemia (T-ALL), can be driven by interactions between leukemic cells and the microenvironment that promote survival of leukemic cells. The bone marrow, an important leukemia niche, has low oxyg...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Blood Adv
Autors principals: Fahy, Lucine, Calvo, Julien, Chabi, Sara, Renou, Laurent, Le Maout, Charly, Poglio, Sandrine, Leblanc, Thierry, Petit, Arnaud, Baruchel, André, Ballerini, Paola, Naguibneva, Irina, Haddad, Rima, Arcangeli, Marie-Laure, Mazurier, Frederic, Pflumio, Francoise, Uzan, Benjamin
Format: Artigo
Idioma:Inglês
Publicat: American Society of Hematology 2021
Matèries:
Lymphoid Neoplasia
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7839374/
https://ncbi.nlm.nih.gov/pubmed/33496749
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020002832
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars